GOLDMAN SACHS GROUP INC - TELA BIO INC ownership

TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 68 filers reported holding TELA BIO INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.9%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TELA BIO INC
ValueSharesWeighting
Q2 2024$722,620
+910.8%
153,749
+1119.4%
0.00%
Q1 2024$71,493
-80.9%
12,609
-64.1%
0.00%
Q1 2023$374,049
+48.4%
35,155
+78.8%
0.00%
Q4 2021$252,000
-20.5%
19,662
-15.3%
0.00%
Q3 2021$317,000
-18.5%
23,220
-3.7%
0.00%
Q2 2021$389,000
+27.1%
24,123
+17.6%
0.00%
Q1 2021$306,0000.0%20,518
+0.9%
0.00%
Q4 2020$306,000
-39.8%
20,342
-33.7%
0.00%
Q3 2020$508,00030,6860.00%
Other shareholders
TELA BIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 1,475,293$24,401,00012.96%
Opaleye Management Inc. 362,074$5,989,0001.17%
COWEN AND COMPANY, LLC 409,004$6,765,0001.10%
SANDERS MORRIS HARRIS LLC 163,121$2,698,0000.73%
Millrace Asset Group, Inc. 53,197$880,0000.71%
Orbimed Advisors 3,027,542$50,076,0000.63%
RTW INVESTMENTS, LP 1,378,776$22,805,0000.55%
PURA VIDA INVESTMENTS, LLC 288,605$4,774,0000.25%
Alyeska Investment Group, L.P. 461,197$7,628,0000.12%
ARMISTICE CAPITAL, LLC 160,000$2,646,0000.10%
View complete list of TELA BIO INC shareholders